Zobrazeno 1 - 10
of 2 540
pro vyhledávání: '"somatostatin analogs"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 581-586 (2024)
Introduction: Lung neuroendocrine tumors (NETs) are a rare type of pulmonary tumor and represent approximately 2% of all lung cancers. The prevalence of lung NETs is increasing, which may be due to improved diagnostic techniques for asymptomatic tumo
Externí odkaz:
https://doaj.org/article/5911d345e1784cbeb5b58ce98776c3ae
Autor:
Anke Tönjes, Marleen Würfel, Marcus Quinkler, Ulrich J. Knappe, Jürgen Honegger, Nina Krause-Joppig, Konrad Bacher, Timo Deutschbein, Sylvère Störmann, Jochen Schopohl, Sebastian M. Meyhöfer, the participants of the German Acromegaly Registry
Publikováno v:
Reproductive Biology and Endocrinology, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Context Acromegaly is a rare disease caused by excessive growth hormone (GH) secretion, mostly induced by pituitary adenomas. The care of pregnant women with acromegaly is challenging, in part due to existing clinical data being limited and
Externí odkaz:
https://doaj.org/article/91dde4d6e61c417a9b4449784289f2ea
Autor:
Pitchaporn Yingchoncharoen, Kavya Bharathidasan, Jerapas Thongpiya, Diego Bernal, Mahmoud Abdelnabi
Publikováno v:
Clinical Case Reports, Vol 12, Iss 7, Pp n/a-n/a (2024)
Key Clinical Message Neuroendocrine tumors, rare and slow‐growing, primarily affect the gastrointestinal tract, causing symptoms due to hormone secretion or mass effect. This case image described postprandial abdominal pain as an atypical initial p
Externí odkaz:
https://doaj.org/article/8c20594b54c34dd88d69c8dbaec746fa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. Romiani, K. Simonsson, D. Pettersson, A. Al-Awar, N. Rassol, H. Bakr, D.E. Lind, G. Umapathy, J. Spetz, R.H. Palmer, B. Hallberg, K. Helou, E. Forssell-Aronsson
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e31409- (2024)
Background: Patients with high-risk neuroblastoma (NB) have a 5-year event-free survival of less than 50 %, and novel and improved treatment options are needed. Radiolabeled somatostatin analogs (SSTAs) could be a treatment option. The aims of this w
Externí odkaz:
https://doaj.org/article/d28f2510adf34997af7efed2df1db8f7
Publikováno v:
Clinical Case Reports, Vol 12, Iss 3, Pp n/a-n/a (2024)
Key Clinical Message Neuroendocrine tumors (NETs) are a group of uncommon neoplasms derived from enterochromaffin or Kulchitsky cells (that secrete serotonin or other molecules into the bloodstream), which can manifest with symptoms of hormonal overp
Externí odkaz:
https://doaj.org/article/b247c64e85984ed6abe5dc5079855b38
Autor:
Simona Găloiu, Iustin-Daniel Toma, Denisa Isabella Tănasie, Andreea Bărbulescu, Ionela Baciu, Dan Alexandru Niculescu, Raluca Alexandra Trifănescu, Cristina Căpăţînă, Şerban Radian, Cătălina Poiană
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionThe mortality ratio in patients with acromegaly has improved over the last few decades. We aimed to determine the mortality rate and correlated factors in patients with acromegaly before and after the introduction of national protocols fo
Externí odkaz:
https://doaj.org/article/3503672148ff4c67bd445a50de9c1e5c
Autor:
Francesca Corti, Maria Pia Brizzi, Vito Amoroso, Dario Giuffrida, Francesco Panzuto, Davide Campana, Natalie Prinzi, Massimo Milione, Tommaso Cascella, Carlo Spreafico, Giovanni Randon, Simone Oldani, Rita Leporati, Giulia Scotto, Iolanda Pulice, Benedetta Lombardi Stocchetti, Luca Porcu, Jorgelina Coppa, Maria Di Bartolomeo, Filippo de Braud, Sara Pusceddu
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Well-differentiated (WD) neuroendocrine tumors (NETs) are a group of rare neoplasms with limited therapeutic options. Cabozantinib is an inhibitor of multiple tyrosine kinases with a pivotal role in NET pathogenesis, including c-M
Externí odkaz:
https://doaj.org/article/b0d84bc55d694b8ea4f945306481f9f2
Autor:
Charles P. Daniel, Maxwell J. Wagner, Grant E. Borne, Connor J. Plaisance, Shahab Ahmadzadeh, Alfonso Aquino, Sahar Shekoohi, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye
Publikováno v:
Pathophysiology, Vol 30, Iss 3, Pp 377-388 (2023)
Acromegaly is a condition most commonly diagnosed in the fifth decade of life and has numerous treatment options. In this regard, Mycapssa® is the first FDA-approved oral octreotide capsule for treating acromegaly, combining the efficacy of the soma
Externí odkaz:
https://doaj.org/article/3d30e80ed8d0419daffc92b5f0015eda
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.